Animal models of α-synucleinopathy for Parkinson disease drug development.

Koprich, James B

Animal models of α-synucleinopathy for Parkinson disease drug development. [electronic resource] - Nature reviews. Neuroscience Sep 2017 - 515-529 p. digital

Publication Type: Journal Article; Review

1471-0048

10.1038/nrn.2017.75 doi


Animals
Animals, Genetically Modified
Antiparkinson Agents--therapeutic use
Disease Models, Animal
Drug Evaluation, Preclinical
Humans
Parkinson Disease--drug therapy
alpha-Synuclein--genetics